Published in Exp Hematol on September 01, 1992
Trophic macrophages in development and disease. Nat Rev Immunol (2009) 5.37
Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One (2011) 1.92
Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med (1993) 1.62
Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat Commun (2013) 1.58
Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest (1998) 1.51
Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.46
The colony-stimulating factors and cancer. Nat Rev Cancer (2010) 1.44
Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med (2011) 1.34
Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc Natl Acad Sci U S A (1996) 1.28
Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol Cell Biol (2000) 1.27
Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. Am J Pathol (1999) 1.05
Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling. Mol Cell Biol (1995) 1.04
The role of macrophage colony-stimulating factor in hepatic glucan-induced granuloma formation in the osteopetrosis mutant mouse defective in the production of macrophage colony-stimulating factor. Am J Pathol (1994) 0.95
Expression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiation. Proc Natl Acad Sci U S A (1994) 0.94
Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects. Bone (2011) 0.94
Selective reduction in microglia density and function in the white matter of colony-stimulating factor-1-deficient mice. J Neurosci Res (2009) 0.89
CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation. Cell Res (2014) 0.87
Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol Cell Biol (1998) 0.86
Could a B-1 cell derived phagocyte "be one" of the peritoneal macrophages during LPS-driven inflammation? PLoS One (2012) 0.85
Colony-stimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis. Infect Immun (1996) 0.84
CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response. PLoS One (2013) 0.84
Effects of macrophage colony-stimulating factor on macrophages and their related cell populations in the osteopetrosis mouse defective in production of functional macrophage colony-stimulating factor protein. Am J Pathol (1996) 0.84
Colony-stimulating factor 1-dependent cells protect against systemic infection with Listeria monocytogenes but facilitate neuroinvasion. Infect Immun (2002) 0.82
Increased connective tissue extracellular matrix in the op/op model of osteopetrosis. Pathobiology (2009) 0.79
Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets. J Biomed Sci (2013) 0.79
The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure. Respir Res (2014) 0.77
Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development. Mol Cell Biol (2011) 0.77
The colony-stimulating factors and cancer. Cancer Immunol Res (2013) 0.76
Type I interferons inhibit the generation of tumor-associated macrophages. Cancer Immunol Immunother (2009) 0.75
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 6.45
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A (1990) 5.05
A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia (2006) 4.39
Synthesis of mouse haemoglobin and globin mRNA in leukaemic cell cultures. Nat New Biol (1972) 3.50
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol (1986) 3.12
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1974) 2.22
Mistyping ACE heterozygotes. PCR Methods Appl (1993) 2.19
Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia (2006) 2.17
Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood (2001) 1.98
The chicken lysozyme 5' matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. Mol Cell Biol (1990) 1.98
Nucleic acid therapeutics: state of the art and future prospects. Blood (1998) 1.96
Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.96
Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J Virol (1987) 1.90
Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc Natl Acad Sci U S A (1985) 1.88
Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. J Virol (1980) 1.85
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia (2009) 1.80
Mixed leukocyte stimulation of normal peripheral leukocytes by autologous lymphoblastoid cells. Science (1970) 1.79
Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart (2007) 1.75
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood (1995) 1.69
Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.68
STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci U S A (1994) 1.67
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol (1991) 1.62
Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.60
The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells (2001) 1.59
Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci U S A (1987) 1.57
Induction of endogenous and of spleen focus-forming viruses during dimethylsulfoxide-induced differentiation of mouse erythroleukemia cells transformed by spleen focus-forming virus. Proc Natl Acad Sci U S A (1975) 1.55
In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester. J Immunol Methods (1973) 1.54
Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia (2005) 1.51
Design of 5' untranslated sequences in retroviral vectors developed for medical use. J Virol (1999) 1.48
An antigenic marker for human thymic lymphocytes. J Immunol (1973) 1.46
Cytokine regulation of the macrophage (M phi) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol Rev (1996) 1.46
Size, subunit composition, and secondary structure of the Friend virus genome. J Virol (1976) 1.45
Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ (1979) 1.43
Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia (2010) 1.43
Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J Immunol (1989) 1.42
Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol (1998) 1.42
Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol (1995) 1.42
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Differential effectiveness of complement fixed by IgG and IgM antibodies in the cytolysis of dog kidney tissue culture cells. Immunology (1966) 1.41
Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis. J Virol (1984) 1.39
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotides. J Exp Med (1973) 1.37
Dimethylsulfoxide-induced differentiation and hemoglobin synthesis in tissue cultures of rat erythroleukemia cells transformed by 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci U S A (1976) 1.37
SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood (1999) 1.36
Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization. J Exp Med (1974) 1.35
Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants. Cell (1988) 1.34
Globin synthesis in Friend-erythroleukemia mouse cells in protein- and lipid-free medium. Effects of dimethyl-sulfoxide, iron and erythropoietin. Exp Cell Res (1974) 1.32
Action of 5-bromodeoxyuridine on the induction of haemoglobin synthesis in mouse leukaemia cells resistant to 5-BUdR. Nat New Biol (1973) 1.31
Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin Exp Immunol (1975) 1.31
Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med (1973) 1.30
Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Virology (1986) 1.30
Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins. Appl Microbiol (1974) 1.30
D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways. Proc Natl Acad Sci U S A (1997) 1.30
Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. Mol Cell Biol (1986) 1.29
Surface changes in differentiating Friend erythroleukemic cells in culture. Cell (1977) 1.28
Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell Tissue Res (2007) 1.27
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus. Proc Natl Acad Sci U S A (1974) 1.26
Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke. Leukemia (2006) 1.25
Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol (2000) 1.24
Plasma and spinal-fluid blocking factor in SSPE. N Engl J Med (1973) 1.23
Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood (2000) 1.22
Friend virus release and induction of haemoglobin synthesis in erythroleukaemic cells respond differently to interferon. Nature (1974) 1.21
Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice--novel view on Igf-1, stem cells and aging. Leukemia (2011) 1.20
Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants. J Virol (1984) 1.20
Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma. Cancer (1995) 1.19
Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol (2001) 1.18
Bursting atlantal fracture associated with rupture of the transverse ligament. J Bone Joint Surg Am (1970) 1.17
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. J Clin Invest (1975) 1.16
Solitary bone cyst: treatment with freeze-dried cancellous bone allograft. A study of one hundred seventy-seven cases. J Bone Joint Surg Am (1969) 1.14
Establishment of a human fetal cardiac myocyte cell line. In Vitro Cell Dev Biol (1991) 1.13
Surface antigens on Schistosoma mansoni. II. Adsorption of a Forssman-like host antigen by schistosomula. Clin Exp Immunol (1972) 1.12
Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol (1975) 1.12
Formation of a new social group of unfamiliar female rhesus monkeys affects the immune and pituitary adrenocortical systems. Brain Behav Immun (1991) 1.11
Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood (1998) 1.11
Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol (1990) 1.11
Studies of cellular differentiation by automated cell separation. Two model systems: Friend virus-transformed cells and Hydra attenuata. J Histochem Cytochem (1976) 1.11
Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. Hum Gene Ther (1991) 1.11
CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol Ther (2000) 1.10
Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys. J Med Primatol (1990) 1.10
Solitary unicameral bone cyst: treatment with freeze-dried crushed cortical-bone allograft. A review of one hundred and forty-four cases. J Bone Joint Surg Am (1976) 1.08
Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination. Nucleic Acids Res (1995) 1.08
Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line. Growth Factors (1993) 1.08
Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus. Virology (1980) 1.08